These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 1625625)
1. Resistance to ciprofloxacin of respiratory pathogens in patients with cystic fibrosis. Hurley JC; Grimwood K; Williams T Med J Aust; 1992 May; 156(9):662-3. PubMed ID: 1625625 [No Abstract] [Full Text] [Related]
2. Development of resistance to ciprofloxacin in nutrient-rich and nutrient-limited growth conditions in vitro by Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Ferguson MI; Scott EM; Collier PS Antimicrob Agents Chemother; 1991 Dec; 35(12):2649-51. PubMed ID: 1810202 [TBL] [Abstract][Full Text] [Related]
3. Reclassification of CLSI criteria for ciprofloxacin and levofloxacin susceptibility against Pseudomonas aeruginosa: Implications for patients with cystic fibrosis (CF). Millar BC; Malnarcic CM; McCaughan J; Moore JE Clin Respir J; 2020 Jan; 14(1):64-68. PubMed ID: 31663261 [No Abstract] [Full Text] [Related]
4. Resistance to ciprofloxacin of respiratory pathogens in patients with cystic fibrosis. Dostal RE; Seale JP; Yan BJ Med J Aust; 1992 Jan; 156(1):20-4. PubMed ID: 1734188 [TBL] [Abstract][Full Text] [Related]
5. Comparison of inhibitory and bactericidal activity of antipseudomonal antibiotics against Pseudomonas aeruginosa isolates from cystic fibrosis patients. Ansorg R; Müller KD; Wiora J Chemotherapy; 1990; 36(3):222-9. PubMed ID: 2110878 [TBL] [Abstract][Full Text] [Related]
6. Effect of ciprofloxacin in an in-vitro pharmacokinetic model against Pseudomonas aeruginosa isolated during cystic fibrosis lung infection. Stevenson MI; Scott EM; Collier PS J Antimicrob Chemother; 1988 Oct; 22(4):491-8. PubMed ID: 3144524 [TBL] [Abstract][Full Text] [Related]
7. [In vitro effect of various antibiotics: beta lactams, aminoglycosides and fluoroquinolones alone and in combination against P. aeruginosa isolated from patients with mucoviscidosis]. Croize J; Gout JP; Robert J; Le Noc P Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):573-7. PubMed ID: 2508041 [TBL] [Abstract][Full Text] [Related]
8. Effective strategies for managing new Pseudomonas cultures in adults with cystic fibrosis. Ali H; Orchard C; Mariveles M; Scott S; Alshafi K; Bilton D; Simmonds N Eur Respir J; 2015 Sep; 46(3):862-5. PubMed ID: 25882803 [No Abstract] [Full Text] [Related]
9. Synergy of ciprofloxacin with fosfomycin in vitro against Pseudomonas isolates from patients with cystic fibrosis. Figueredo VM; Neu HC J Antimicrob Chemother; 1988 Jul; 22(1):41-50. PubMed ID: 3139615 [TBL] [Abstract][Full Text] [Related]
15. In-vitro activity of ciprofloxacin and other antibacterial agents against Pseudomonas aeruginosa and Pseudomonas cepacia from cystic fibrosis patients. Klinger JD; Aronoff SC J Antimicrob Chemother; 1985 Jun; 15(6):679-84. PubMed ID: 3161856 [TBL] [Abstract][Full Text] [Related]
16. Investigation into the selection frequency of resistant mutants and the bacterial kill rate by levofloxacin and ciprofloxacin in non-mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients. Gillespie T; Masterton RG Int J Antimicrob Agents; 2002 May; 19(5):377-82. PubMed ID: 12007845 [TBL] [Abstract][Full Text] [Related]
17. Antibiotic resistance evolution of Pseudomonas aeruginosa in cystic fibrosis patients (2010-2013). Lucca F; Guarnieri M; Ros M; Muffato G; Rigoli R; Da Dalt L Clin Respir J; 2018 Jul; 12(7):2189-2196. PubMed ID: 29498795 [TBL] [Abstract][Full Text] [Related]
18. Canadian Pseudomonas aeruginosa susceptibility study from 48 medical centers: focus on ciprofloxacin. Blondeau JM; Suter ME; Borsos S; Misfeldt C Int J Antimicrob Agents; 1998 Nov; 10(4):297-302. PubMed ID: 9916904 [TBL] [Abstract][Full Text] [Related]
19. Susceptibility of Pseudomonas aeruginosa and Escherichia coli biofilms towards ciprofloxacin: effect of specific growth rate. Evans DJ; Allison DG; Brown MR; Gilbert P J Antimicrob Chemother; 1991 Feb; 27(2):177-84. PubMed ID: 1905285 [TBL] [Abstract][Full Text] [Related]
20. Ciprofloxacin during upper respiratory tract infections to reduce Pseudomonas aeruginosa infection in paediatric cystic fibrosis: a pilot study. Connett GJ; Pike KC; Legg JP; Cathie K; Dewar A; Foote K; Harris A; Faust SN Ther Adv Respir Dis; 2015 Dec; 9(6):272-80. PubMed ID: 26341118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]